Status:
COMPLETED
Fenoldopam and Acute Renal Failure
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Acute Renal Failure
Eligibility:
All Genders
18-99 years
Phase:
PHASE3
Brief Summary
Patients undergoing cardiac surgery could develop postoperative acute renal failure requiring renal replacement therapy. Fenoldopam, already used for patients with hypertensive emergencies, could imp...
Eligibility Criteria
Inclusion
- adult patients
- who underwent cardiac surgery
- have Risk of Acute Renal Failure (R of RIFLE score)
Exclusion
- glaucoma
- already on renal replacement therapy
- study drug in the past 30 days
- inclusion in other protocols
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
667 Patients enrolled
Trial Details
Trial ID
NCT00621790
Start Date
February 1 2008
End Date
June 1 2013
Last Update
October 14 2015
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
A.O. Universitario Policlinico S.Orsola Malpighi
Bologna, Italy
2
Pres.Ospedal. Spedali Civili Brescia - Brescia
Brescia, Italy
3
Azienda Ospedaliera Universitaria "Mater Domini" Catanzaro
Catanzaro, Italy
4
Azienda Ospedaliero Universitaria Careggi - Firenze
Florence, Italy